Compare · CHE vs LFMD
CHE vs LFMD
Side-by-side comparison of Chemed Corp (CHE) and LifeMD Inc. (LFMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and LFMD operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $7.11B, about 45.4x LFMD ($156.7M).
- LFMD has been more active in the news (8 items in the past 4 weeks vs 7 for CHE).
- LFMD has more recent analyst coverage (11 ratings vs 6 for CHE).
- Company
- Chemed Corp
- LifeMD Inc.
- Price
- -
- -
- Market cap
- $7.11B
- $156.7M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 7
- 8
- Recent ratings
- 6
- 11
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
LifeMD Inc.
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that would offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.
Latest CHE
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)
- VP and Chief Legal Officer Judkins Brian C exercised 6,786 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 5,878 units of Capital Stock, increasing direct ownership by 37% to 3,344 units (SEC Form 4)
- CEO - Vitas Healthcare Wherley Joel L exercised 2,599 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 2,270 units of Capital Stock, increasing direct ownership by 39% to 1,181 units (SEC Form 4)
- Chemed Corporation Declares Quarterly Dividend of 70 Cents
- President and CEO Mcnamara Kevin J covered exercise/tax liability with 19,802 units of Capital Stock, sold $1,079,020 worth of Capital Stock (2,000 units at $539.51) and exercised 2,001 units of Capital Stock at a strike of $445.35, decreasing direct ownership by 22% to 70,418 units (SEC Form 4)
- Director Grace Patrick P sold $101,080 worth of Capital Stock (190 units at $532.00), decreasing direct ownership by 5% to 3,533 units (SEC Form 4)
- SEC Form 10-Q filed by Chemed Corp
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports Second-Quarter 2026 Results
Latest LFMD
- Director Larovere Joan was granted 35,000 shares, increasing direct ownership by 33% to 142,050 units (SEC Form 4)
- Director Strawn John R Jr was granted 85,000 shares, increasing direct ownership by 21% to 498,001 units (SEC Form 4)
- Director Ditrolio Joseph was granted 35,000 shares, increasing direct ownership by 13% to 308,413 units (SEC Form 4)
- Amendment: Director Simon Roberto was granted 80,810 shares, increasing direct ownership by 81% to 180,810 units (SEC Form 4)
- Director Simon Roberto was granted 85,000 shares, increasing direct ownership by 42% to 288,175 units (SEC Form 4)
- Director Macrae Calum Archibald was granted 35,000 shares, increasing direct ownership by 90% to 73,865 units (SEC Form 4)
- SEC Form 10-Q filed by LifeMD Inc.
- LifeMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- LifeMD to Report Second Quarter 2026 Financial Results on August 5
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock